Erythrocyte sodium transport was studied in five families of patients with hereditary spheroeytosis (HS). Values for ouabain-insensitive sodium efilux in the group with HS (mean = 19.9% of cellular sodium-22/hr, so = ±2.7) were significantly greater (P < 0.001) than those found in the normal group (mean = 13.8%, SD = ±2.7). No clinical evidence of HS was found in the parents; however, 4 of the 10 parents had ouabain-insensitive erythrocyte sodium-22 efilux rates in the HS range in comparison to 3 of 30 control subjects, a statistically significant difference (x ! = 4.67; P < 0.05).
Introduction
In hereditary splierocytosis (HS) the erythrocyte membrane is abnormally permeable to sodium [1, 4, 6, 8] ; this tlefcct has been suggested as being responsible for the shortened erythrocyte life span in IIS [6] . In this study, we present evidence contrary to this theory by describing several subjects with little or no evidence of IIS in whom erythrocyte sodium transport is identical to that found in this condition. Furthermore, our data suggest that the gene for HS may manifest itself merely as an increase in sodium permeability with no other hcmalologic abnormality.
Methods
Routine hcmatologic techniques were carried out as described by Dacie [3, 14] . Chromium-51 survival studies were performed by standard techniques [9] .
Studies of sodium-22 efflux and sodium concentration were performed by methods described in the literature [8, 10] and involved prcincubation (1 hr at 37°) of washed crythrocytes in a Tris-KCl buffer (150 HIM KC1, 10 HIM Tris, 10 niM glucose, pH 7.45) containing sodium-22 chloride to load the cells. These cells were then washed and resuspended in buffer (10 ITIM glucose, 135 HIM NaCl, 15 HIM KCI, 10 HIM Tris, pH 7.45) with Erythrocyte sodium flux in sphcrocytosis 615 or without added ouabain (0.05 HIM). Sodium-22 efflux from these suspensions was determined and ouabainsensitive and ouabain-insensitive efflux was calculated. The average difference in day-to-day analysis of 13 control and test subjects was 0.85% (SD ± 0.85%), expressed as percentage of cellular sodium-22/hr.
Following the initial two bulfer washes, sodium concentrations were determined on erythrocytes by direct analysis of packed red cell columns, as described by Zipursky et al. [13] . Since the cells had been washed and resuspended in Tris-KCl buffer, no correction was made for trapped fluids.
Results
Five families formed the experimental unit for these studies. Hereditary spherocytosis had been diagnosed in one child from each of four families and in two children in the fifth family.
Diagnostic features in the affected children included anemia, reticulocytosis, abnormal osmotic fragility and autohemolysis, microspherocytosis, and cure of the hemolytic process by splenectomy.
The families were unusual in that no clinical evidence of HS was found in the parents; normal results were found in each case for hemoglobin concentration, reticulocyte count, serum bilirubin, incubated and nonincubated osmotic fragility, autohemolysis, and morphology of the red blood cells.
Rate constants for ouabain-insensitive sodium-22 efflux for erythrocytes from normal subjects and those witli HS are shown in Figure 1 .
The values found in the group with HS (mean -19.9% of cellular sodium-22/hr, SD = ±2.7) were significantly greater (P < 0.001) than those observed in the normal group (mean -13.8, SD = ±2.7). It should be noted, however, that three subjects in the normal group had rate constant values in the HS range.
Studies of ouabain-insensitive sodium-22 efllux in 4 of the 10 parents were in the HS range (Fig. 1) . The values in these parents, expressed as In two families, K and /•", erythrocyte sodium efflux was normal in both parents. Thus, 4 of 10 parents had rate constants in the HS range in comparison to 3 of 30 control subjects, a statistically significant difference ( X ' J = 4.67; P < 0.05). Three parents were studied further to determine whether any other evidence of HS could be detected. As noted earlier, hematologic measurements were normal, and chromium-51 erythrocyte survivals were the following (50% survival time): Mr. J: 26 days; Mr. M: 23 days; and Mrs. B: 25.5 days. These survivals are low-normal or slightly below the normal range of 25-40 days [9] .
Ouabain-insensitive rates of sodium efflux were determined on two of these subjects, Mr. M and Mrs. B, and the results are shown in Figure 2 . These data are divided on the basis of sex because of previous observations which show that erythrocyte sodium values in men are significantly higher than in women [7] . Our data do indicate that ouabain-insensitive sodium efflux rates in men (mean = 1.13 mEq sodium/liter cells/hr; SD ± 0.15) are significantly greater (P < 0.001) than in women (mean = 0.82 mEq sodium/liter cells/hr; SD ± 0.18). These data appear to reflect the higher sodium concentrations in men (mean = 8.2 mEq/liter cells; SD ± l.G), than in women (mean = 6.3 mEq/liter SD ± 0.8). The difference between these two concentrations is also significant (P < 0.001).
Sodium values in the present study were lower than those in fresh, unwashed erythrocytes [8] . Presumably, the washes in sodium-free buffer lower the sodium content.
The ouabain-insensitive efflux rates for five males Erythrocyte sodium concentrations and ouabain-scnsitive elllux, sodium-potassium pump, however, were normal in all 10 parents.
Discussion
The data in Figures 1 and 2 indicate that ouabain-insensitive sodium transport in patients with HS is significantly greater than in normal subjects (P < 0.001). Ouabain-inscnsitive sodium efllux includes the movement of sodium both by diffusion and by a recently described active process, "pump II" [5] , Our data do not indicate which of these components is increased in MS. This matter is dealt with in greater detail elsewhere [8] . Our findings, however, are consistent with previous observations [1, 4, 6] which suggest that sodium permeability is increased in the erythrocyte membrane in patients with HS.
Certain normal subjects, as well as several parents of patients with IIS, showed ouabain-insensitivc sodium efllux in the MS range, and yet there was little or no evidence of a hcmolylic process. These observations on normal subjects arc consistent with the studies of Wiley [11] , who reported recently that there was no correlation between sodium influx (presumably measuring permeability) and erythrocyte survival in patients with HS. These findings are inconsistent with the thesis that the increased sodium permeability of erythrocytes of patients with HS plays a central role in the pathogenesis of the hemolytic anemia in this disease [6] . It is more likely the case that the increased sodium permeability characteristic of HS merely reflects an erythrocyte membrane defect in this particular disease.
Classically, MS is inherited as a Mendelian dominant. In the five families described in this report, there was no evidence of MS in any of the parents. These families are similar to those described by Dacie [2] and Young [12] . In one family described by Young [12] , one parent had abnormal erythrocyte morphology and osmotic fragility with no evidence of disease.
None of the parents of the five families in this study had abnormal erythrocyte osmotic fragility. Of considerable interest, however, is the fact that 4 of the 10 parents had efflux rates in the MS range, as opposed to a significantly lower incidence (3/30) in the control group (P < 0.05). Although this is a small series, and therefore the results must be interpreted with caution, this observation suggests that some of these parents carried the gene for MS which manifested in them only as an increase in erythrocyte ouabain-insensitive sodium efflux, or membrane permeability. Finally, it should be noted that in two of the families, A' and /•", membrane permeability was normal in both parents; in them there was no demonstrable expression of the gene for HS. In one of these families, F, two of four children had HS, suggesting that the disease, in these children, did not represent a mutation but had been transmitted from one or both of the unaffected parents.
We have interpreted these findings to mean that in addition to classical cases with hemolytic disease, the gene for MS may express itself either as an abnormality in erythrocyte morphology with a normal erythrocyte life span or as an increase in membrane perineability with normal erythrocyte morphology and life span. In some instances no hematologic abnormalities can be found in presumed carriers of the HS gene.
The reasons for these differences in genetic expres-sion are unknown and will remain so until we understand, more fully, the erythrocyte abnormality in HS.
Si / mmary
In hereditary spherocytosis (HS), erythrocyte ouabaininsensitive sodium efllux is greater than normal. In the present study, however, normal subjects are described in whom erythrocyte sodium efflux is in the HS range. These findings contradict the hypothesis that an increase in erythrocyte sodium permeability is responsible for the shortened erythrocyte life span in HS. The finding in the present study of a greater incidence of high efflux rates in hematologically normal parents of patients with HS suggests that the gene for HS may be expressed as an abnormality in erythrocyte sodium efflux with little or no evidence of hcmatologic disease.
